Armata Pharmaceuticals Current Deferred Revenue (Quarterly) Insights

Armata Pharmaceuticals, Inc. (ARMP)

6.14 -0.22 (-3.46%) USD | NYAM | Dec 30, 12:51

View Current Deferred Revenue (Quarterly) for ARMP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Agenus, Inc.	Upgrade
Integer Holdings Corp.	--
Liquidia Corp.	--
AIM ImmunoTech, Inc.	--
Protalix Biotherapeutics, Inc.	Upgrade